Thrombolysis in acute ischemic stroke in patients with dementia
Authors:
- Eva ZupanicEZEva Zupanic
- Mia von EulerMEMia von Euler
- Ingemar KåreholtIKIngemar Kåreholt
- Beatriz Contreras EscamezBEBeatriz Contreras Escamez
- Johan FastbomJFJohan Fastbom
- Bo NorrvingBNBo Norrving
- Dorota ReligaDRDorota Religa
- Milica G. KrambergerMKMilica G. Kramberger
- Bengt WinbladBWBengt Winblad
- Kristina JohnellKJKristina Johnell
- Maria EriksdotterMEMaria Eriksdotter
- Sara Garcia-PtacekSGSara Garcia-Ptacek
Open Access
- 31 October 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 89 (18) , 1860-1868
Abstract
Objective: To compare access to intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) and its outcomes in patients with and without dementia. Methods: This was a longitudinal cohort study of the Swedish dementia and stroke registries. Patients with preexisting dementia who had AIS from 2010 to 2014 (n = 1,356) were compared with matched patients without dementia (n = 6,755). We examined access to thrombolysis and its outcomes at 3 months (death, residency, and modified Rankin Scale [mRS] score). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with logistic and ordinal logistic regression. Results: The median age at stroke onset was 83 years in both groups. IVT was administered to 94 (7.0%) patients with dementia and 639 (9.5%) patients without dementia. The OR of receiving IVT was 0.68 (95% CI 0.54–0.86) for patients with dementia. When the analysis was repeated exclusively among patients independent in everyday activities, dementia status was no longer significant (OR 0.79, 95% CI 0.60–1.06). However, differences persisted in patients ≤80 years of age (OR 0.58, 95% CI 0.36–0.94). In patients who received thrombolysis, the incidence of symptomatic intracerebral hemorrhage (sICH; 7.4% vs 7.3%) and death at 3 months (22.0% vs 18.8%) did not differ significantly between the 2 groups. However, mRS score and accommodation status were worse among patients with dementia after 3 months in adjusted analyses (both p < 0.001). Unfavorable outcomes with an mRS score of 5 to 6 were doubled in patients with dementia (56.1% vs 28.1%). Conclusions: Younger patients with dementia and AIS are less likely to receive IVT. Among patients receiving thrombolysis, there are no differences in sICH or death, although patients with dementia have worse accommodation and functional outcomes at 3 months.Keywords
This publication has 23 references indexed in Scilit:
- Management of acute ischaemic stroke in patients with dementiaJournal of Internal Medicine, 2017
- Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke PopulationCirculation, 2017
- Causes of Death According to Death Certificates in Individuals with Dementia: A Cohort from the Swedish Dementia RegistryJournal of the American Geriatrics Society, 2016
- Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before StrokeStroke, 2016
- Cardiovascular Diseases in ∼30,000 Patients in the Swedish Dementia RegistryJournal of Alzheimer’s Disease, 2015
- SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical PracticePLOS ONE, 2015
- Mortality Risk after Dementia Diagnosis by Dementia Type and Underlying Factors: A Cohort of 15,209 Patients based on the Swedish Dementia RegistryJournal of Alzheimer’s Disease, 2014
- Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysisJournal of Neurology, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Riks-Stroke – A Swedish National Quality Register for Stroke CareCerebrovascular Diseases, 2003